Euglena Co Ltd
TSE:2931
Euglena Co Ltd
Cash from Financing Activities
Euglena Co Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Euglena Co Ltd
TSE:2931
|
Cash from Financing Activities
¥5.8B
|
CAGR 3-Years
230%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Shiseido Co Ltd
TSE:4911
|
Cash from Financing Activities
-¥75.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-8%
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Cash from Financing Activities
-¥13.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-41%
|
CAGR 10-Years
-23%
|
|
Pola Orbis Holdings Inc
TSE:4927
|
Cash from Financing Activities
-¥12.4B
|
CAGR 3-Years
23%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-16%
|
|
Kao Corp
TSE:4452
|
Cash from Financing Activities
-¥80B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-2%
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Cash from Financing Activities
-¥19.5B
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
-18%
|
See Also
What is Euglena Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
5.8B
JPY
Based on the financial report for Dec 31, 2023, Euglena Co Ltd's Cash from Financing Activities amounts to 5.8B JPY.
What is Euglena Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
20%
The average annual Cash from Financing Activities growth rates for Euglena Co Ltd have been 230% over the past three years , 20% over the past five years .